F
Franz Fazekas
Researcher at Medical University of Graz
Publications - 634
Citations - 59050
Franz Fazekas is an academic researcher from Medical University of Graz. The author has contributed to research in topics: Hyperintensity & Stroke. The author has an hindex of 101, co-authored 629 publications receiving 49775 citations. Previous affiliations of Franz Fazekas include Hospital of the University of Pennsylvania & University of Graz.
Papers
More filters
Journal ArticleDOI
Features of intracranial hemorrhage in cerebral venous thrombosis.
K. Afifi,K. Afifi,G Bellanger,Pieter-Jan Buyck,Susanna M. Zuurbier,Carlos Garcia Esperon,Miguel A Barboza,Patricia Luiza Nunes Costa,Irene Escudero,Dimitri Renard,Robin Lemmens,Nicole Hinteregger,Franz Fazekas,J. Jiménez Conde,Eva Giralt-Steinhauer,Sini Hiltunen,Antonio Arauz,Alessandro Pezzini,Joan Montaner,Joan Montaner,Joan Montaner,Jukka Putaala,Christian Weimar,Marc Schlamann,Thomas Gattringer,Turgut Tatlisumak,Turgut Tatlisumak,Turgut Tatlisumak,Jonathan M. Coutinho,Philippe Demaerel,Vincent Thijs +30 more
TL;DR: The high rate of intracranial hemorrhage in cerebral venous thrombosis is not explained by widespread involvement of the venous sinuses, and superior sagittal sinus involvement is associated with higher bleeding risk.
Journal ArticleDOI
Relaxation time mapping in multiple sclerosis.
TL;DR: The broad spectrum of the pulse sequences and analysis techniques related to multiple sclerosis that are currently available will be covered, including acquisition time, accuracy and precision, radiofrequency absorption and limited coverage of the brain.
Journal ArticleDOI
Relevance of Neuroimaging in the Evaluation of Cerebral Ischemia
TL;DR: A diagnostic algorithm which is tailored according to stroke phase and availability of distinct therapeutic strategies is proposed, which allows identification of individuals at a specifically high risk for a subsequent stroke.
Journal ArticleDOI
Recommendations for the use of prolonged-release fampridine in patients with multiple sclerosis (MS).
Jana Lizrova Preiningerova,Ulf Baumhackl,Tünde Csépány,Adam Czaplinski,Florian Deisenhammer,Tobias Derfuss,Tanja Hojs Fabjan,Franz Fazekas,Siegrid Fuchs,Eva Havrdova,Alenka Horvath Ledinek,Zsolt Illes,Saša Šega Jazbec,Eleonóra Klímová,Sámuel Komoly,Egon Kurča,Michael Linnebank,Lubomir Lisy,Jan Mares,Lubica Prochazkova,Rozsa Csilla,Jarmila Szilasiova,Pavel Štourač,Radomír Taláb,Peter Turcani,Marta Vachová,László Vécsei,David B. Vodušek,Olga Zapletalová,Thomas Berger +29 more
TL;DR: Fampridine PR has been approved to improve speed of walking in patients with multiple sclerosis and recommendations on practical use of the medication in clinical practice, prediction, and evaluation of response to treatment and patient management are provided.
Journal ArticleDOI
Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis
Michael Khalil,B. Riedlbauer,Christian Langkammer,Christian Enzinger,S. Ropele,Tatjana Stojakovic,Hubert Scharnagl,V. Culea,Axel Petzold,Charlotte E. Teunissen,Juan J. Archelos,Siegrid Fuchs,Franz Fazekas +12 more
TL;DR: Evidence is provided that altered iron homeostasis within the brain occurs in the very early phases of the disease, and it is suggested that the transporter protein transferrin may play a role in the increased iron deposition known to occur in the brain of MS patients.